methotrexatemercaptopurine6-MPmethotrexate-resistantMTX6-mercaptopurineMTX-resistant
…aintenance therapy (MT) consisting of mercaptopurine (6-MP) and methotrexate (MTX). Evidence suggests promising clinical outcomes from the u…
Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
…aintenance therapy (MT) consisting of mercaptopurine (6-MP) and methotrexate (MTX). Evidence suggests promising clinical outcomes from the u…
… ≥2, and inadequate response/intolerance (IR) to TNFa blockers, vedolizumab, ustekinumab, JAK inhibitors, or S1P receptor modulators (BIO/J…